NCT01250470 2017-02-27Vaccine Therapy and Sargramostim in Treating Patients With Malignant GliomaRoswell Park Cancer InstitutePhase 1 Completed9 enrolled
NCT01403285 2014-05-19Peptide-based Glioma Vaccine IMA950 in Patients With GlioblastomaImmatics Biotechnologies GmbHPhase 1 Terminated6 enrolled